| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Haemonetics Corp (HAE) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 69 sells. HAE is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 28.9K | $2.24M | - | |
| Dir | 25.0K | $1.94M | - | |
| Dir | 24.8K | $1.92M | - | |
| Dir | 19.4K | $1.50M | - | |
| Dir | 16.9K | $1.31M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 7, 2018 | Basil Michelle L51 | EVP And General Counsel | Sell | 457 | $92.73 | $42,377.61 | -4.1% | |
| Jun 7, 2018 | Simon, Christopher | President &CEO | Sell | 1,941 | $92.73 | $179,988.93 | -1.5% | |
| Jun 7, 2018 | Goldstein Dan | VP, Corporate Controller | Sale+OE | 3,794 | $95.09 | $360,765.95 | -23.9% | |
| Apr 6, 2018 | Goldstein Dan | VP, Corporate Controller | Sell | 518 | $54.65 | $28,307.09 | -4.3% | |
| Mar 6, 2018 | Scanlan Jacqueline48 | SVP, Global Human Resources | Sell | 114 | $72.23 | $8,234.22 | -2.5% | |
| Mar 6, 2018 | Basil Michelle L51 | EVP And General Counsel | Sell | 389 | $72.23 | $28,097.47 | -3.5% | |
| Jan 2, 2018 | Kroll Mark W | Director | Sale+OE | 7,118 | $63.00 | $448,434.00 | -21.0% | |
| Dec 1, 2017 | Granadillo Pedro P | Director | Sale+OE | 7,118 | $57.06 | $406,184.40 | -1.0% | |
| Nov 16, 2017 | Gelbman Ronald G | Director | Sale+OE | 5,440 | $56.69 | $308,404.15 | -0.5% | |
| Nov 14, 2017 | Burke Willaim P54 | EVP, Chief Financial Officer | Sale+OE | 13,193 | $54.04 | $712,901.21 | -4.6% |